A who's who of the intellectual property rights world, including science professors, patent lawyers, judges and corporate intellectual property experts, will visit New Delhi, Mumbai, Bangalore,......
Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third......
'It is not just the US and European opportunity, but it is a huge global opportunity.' Photograph: Kind courtesy Biocon The peptides and GLP-1 class of drugs that are offering breakthrough......
Bristol-Myers Squibb India, the wholly owned subsidiary of the $19.2 billion US pharmaceutical company, has launched Baraclude, its anti-Hepatitis B drug in India.Baraclude, an entecavir oral......
With product patents set to kick in by 2005, the few big multinational drug companies that had kept India out of their plans are having a change of heart. To begin with, Bristol-Myers Squibb, the......
Aurobindo Pharma has received licences from Bristol Myers Squibb Co to market two anti-AIDS drugs in 49 countries. The licences are for Stavudine and Didanosine, Aurobindo said.The licence allows......